Skip to main content
# Title Research Member Research Year
111 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

Prof. Ashraf Zeidan Abdalla Ahmed 2020
112 Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center Dr. Salah Mabrouk Khallaf Abd Rabou 2020
113 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
Dr. Abeer Elsayed Ali Ibrahim 2020
114 Age and Tumor Location Predict Survival in Nonmetastatic Osteosarcoma in Upper Egypt Dr. Hanaan Ahmed Mohammed Ahmed 2020
115 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Dr. Amen Hamdy Zaki Ali 2019
116 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Nehal Adel Rayan Mohammed 2019
117 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Dr. Mayada Fawzy Sedik Farghaly 2019
118 The Prognostic Implication of CD49d Expression by Flow Cytometry and Trisomy 12 Detection by Fluorescent in situ Hybridization in Chronic Lymphocytic Leukemia Dr. Mayada Fawzy Sedik Farghaly 2019
119 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Nehal Adel Rayan Mohammed 2019
120 Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients (South Egypt Cancer Institute Experience) Dr. Abeer Elsayed Ali Ibrahim 2019